
==== Front
Blood Sci
Blood Sci
BS9
Blood Science
2543-6368
Lippincott Williams & Wilkins Hagerstown, MD

00004
10.1097/BS9.0000000000000185
3
Erratum
Erratum: Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia
07 3 2024
4 2024
07 3 2024
6 2 e00185e00185
Copyright © 2024 The Authors. Published by Wolters Kluwer Health Inc., on behalf of the Chinese Medical Association (CMA) and Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (IHCAMS).
2024
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

OPEN-ACCESSTRUE
==== Body
pmcIn the original publication of our paper, “Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia,” published on Blood Science, 2024 Jan; 6(1): e00179, we have identified several errors that require correction. We apologize for any inconvenience caused and appreciate the opportunity to clarify the following:

In Abstract, the post-relapse overall survival of patients in the escalation group and the non-escalation group (median, not reached vs. 50.7 months, respectively, P=0.039) was incorrectly reported.

In Results of 3.6, the post-relapse overall survival of patients in the escalation group and the non-escalation group (median, not reached vs. 50.7 months, respectively, P=0.039) was incorrectly reported.

Correction:

Patients in the escalation group also had longer post-relapse overall survival compared with the non-escalation group (median, not reached vs. 50.7 months, respectively, P=0.039).

The escalation group exhibited longer PFS2 (median, 50.4 months vs. 23.5 months, P <0.001) and post-relapse overall survival time (median, not reached vs. 50.7 months, respectively, P=0.039) than the non-escalation group (Figure 6A–B).

These corrections do not significantly impact the overall findings and conclusions of the paper. We would like to assure readers that the corrected values do not alter the interpretations or validity of the research.
==== Refs
Reference

1. Yu Y Xiong W Wang T . Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia. Blood Sci 2024;6 (1 ):e00179. DOI: 10.1097/BS9.0000000000000179 38239572
